Neuromyelitis Optica (NMO)

Main Article Content

Parkpoom Grasaelap, MD


NMO is a is a rare entity which involves the central nervous system acting as an inflammatory process by attacking the optic nerve (ON) and longitudinally extensive transverse myelitis (LETM). The specificity of this disease is antibody aquaporin-4 (AQP4). Repeated relapses of the disease can lead to severe disability and blindness. MRI is none specific but at the cervical spinal cord shows the long extensive contrast enhancement. The specific diagnosis is NMO IgG.


Download data is not yet available.

Article Details

How to Cite
Grasaelap P. Neuromyelitis Optica (NMO). BKK Med J [Internet]. 2019 Oct. 4 [cited 2023 Dec. 2];8(1):39. Available from:
Case Report


1. Wingerchu DM, ennon A, ucchinetti , et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-15.
2. Lanon A, ingerchu DM, ryer T, et al. A serum autoantibody marer of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12.
3. Morro MJ, ingerchu D. euromyelitis optica. J Neuroophthalmol 2012;32:154-66.
4. Siritho, Prayooniat. A retrospective study of multiple sclerosis in irira ospital, ango, Thailand. Neurology Asia 2006;11:55-61.
5. Lalan, han M, chlaman, et al. Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging. Int J MS Care 2012;14:209-14.
6. Wingerchu DM, anon , Pittoc J, et al. evised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
7. Pittoc J, ennon A, de ee J, et al. euromyelitis optica spectrum disorders and non organ-specific auto-immunity. Arch Neurol 2008;65:78-83.
8. Wingerchu DM. Diagnosis and treatment of neuro-myelitis optica. Neurologist 2007;13:2-11.